Journal section: Oral Medicine and Pathology Publication Types: Research
Survival study of leukoplakia malignant transformation in a region of northern Spain
Pilar Gandara-Vila 1, Mario Pérez-Sayans 2, Jose M. Suárez-Peñaranda 3, Mercedes Gallas-Torreira 4, Jose Somoza-Martín 4, Maria-Dolores Reboiras-López 4, Andrés Blanco-Carrión 4, Abel García-García 5
1 PhD, DDS. Oral Medicine, Oral Surgery and Implantology Unit. Faculty of Medicine and Dentistry, Santiago de Compostela, Spain
2 PhD, DDS. Oral Medicine, Oral Surgery and Implantology Unit. Faculty of Medicine and Dentistry. Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain
3 MD, PhD. Department of Pathology and Forensic Sciences. University Hospital and School of Medicine of Santiago de Com- postela
4 PhD, DDS. Oral Medicine, Oral Surgery and Implantology Unit. Faculty of Medicine and Dentistry. Santiago de Compostela, Spain
5 MD, PhD. Oral Medicine, Oral Surgery and Implantology Unit. Faculty of Medicine and Dentistry. Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain
Correspondence:
Oral Medicine, Oral Surgery and Implantology Unit Faculty of Medicine and Dentistry
Entrerríos s/n, Santiago de Compostela C.P. 15705 pilar.gandara@usc.es
Received: 22/12/2017 Accepted: 09/05/2018
Abstract
Background: Oral leukoplakia is the most common potentially malignant disorder (PMD) of the oral cavity. The objectives of this study are to determine the clinicopathologic features in a group of patients with oral leukoplakia of Northern Spain (Galicia), determining the factors associated to clinical risk and analyzing the malignant trans- formation of these patients.
Material and Methods: We included 85 patients. We recorded sex and age, habits like alcohol and tobacco, size, clinical appearance, site, number of lesions, and presence or absence of dysplasia. We assess the association between risk factors and transformation and developed a logistic regression analysis. Finally we used the Kaplan- Meier and log-rank test for the survival analysis.
Results: 7 patients (8.2%) had malignant transformation. The mean follow-up of the patients was 4.13 years ver- sus 5.58 years of those who developed carcinoma. Only location and initial dysplasia have a statistically significant relationship with malignant transformation, but when applied the long rank test only the presence of dysplasia remains statistically significant(P<0,026). Oral Cancer Free Survival was 81.9% (0.150) at 11 years for the group without dysplasia.
doi:10.4317/medoral.22326
http://dx.doi.org/doi:10.4317/medoral.22326
Gandara-Vila P, Pérez-Sayans M, Suárez-Peñaranda JM, Gallas-Torreira M, Somoza-Martín J, Reboiras-López MD, Blanco-Carrión A, García- García A. Survival study of leukoplakia malignant transformation in a region of northern Spain. Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 (4):e413-20.
http://www.medicinaoral.com/medoralfree01/v23i4/medoralv23i4p413.pdf Article Number: 22326 http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946 eMail: medicina@medicinaoral.com
Indexed in:
Science Citation Index Expanded Journal Citation Reports Index Medicus, MEDLINE, PubMed Scopus, Embase and Emcare Indice Médico Español
Conclusions: We found that the presence of dysplasia is the only risk factor that is statistically related to the develop- ment of a carcinoma.
Key words: Leukoplakia, oral cancer and oral precancer, follow-up, malignant transformation.
Introduction
Oral leukoplakia is the most common potentially ma- lignant lesion of the oral cavity, it is estimated that the overall prevalence is 1.72-2.60% (1). It is defined as “a white plate of questionable risk, having excluded (other) known diseases or disorders that do not increase the risk of cancer” (2).
Most leukoplakia lesions are benign lesions. A per- centage of these acquire progressive dysplastic changes (3) and finally can result in the development of a car- cinoma (4). The percentage of malignancy varies from one study to another, reaching a range from 0.13% (5) to 34% (6); if we consider only the form of proliferative verrucous leukoplakia can reach 70.3.% (7). Today we still don’t have the means at our disposal that allows us to know the prognosis of an individual lesion (8,9).
In literature there are certain risk factors associ- ated with malignant transformation such as advanced age (3,10,11), female sex (12), idiopathic leukoplakia (non-smokers) (11,13), long evolution (14), size above 200mm2 (15,16) or length of major axis of more than 4 mms (17), non homogeneous clinical form (11,18,19), the subsite of tongue and floor of the mouth (20) and the presence of dysplasia (10,21-23). But the results vary when we compare different studies.
The objectives of this study are to determine the clinical and pathological features of leukoplakia of the oral cav- ity in our area in a group of 85 patients from Northern Spain (Galicia), and identifying the factors associated to malignant transformation and doing a study of survival of patients with this disease.
Material and Methods -Patients
Patients clinically diagnosed with oral leukoplakia were selected from the database of patients who attended the Oral Medicine Unit Clinic of the School of Dentistry at the University of Santiago de Compostela between January 1995 and June 2010.
This study complied with the Helsinki Declaration. The study received the approval of the ethics committee of the Galician Department of Health .
-Inclusion and exclusion criteria
Patients with clinical leukoplakia lesions (as defined by the WHO(2) in 2005:” white plaques of questionable risk having excluded (other) known diseases or disor- ders that carry no increased risk for cancer”) were in- cluded, such cases were confirmed by incisional or ex- cisional biopsy (diagnostic certainty 3 and 4, using Van der Waal’s classification), of which we obtained access
to the clinical history, clinical images of the lesion and the anatomic-pathological material.
Exclusion criteria were: 1) Lack of initial histological diagnosis; 2) follow-up period of less than one year; 3) lesion with clinical appearance or histological findings white, or predominantly white, benign disease such as leukoedema, linea alba, potentially malignant lesions such as lichen planus, discoid lupus erythematosus, etc.
4) lack of initial clinical image of the lesion; 5) lack of access to the histological material allowing for confir- mation of the initial diagnosis; 6) presence of a concom- itant carcinoma or diagnosed within 6 months after the initial diagnosis.
Of the 90 patients who met the inclusion requirements established for the study, we excluded 5 who showed a carcinoma in the first biopsy or who were diagnosed with one in less than 6 months after their first visit.
-Clinical data
Demographic data (sex and age) and clinical data rel- evant to leukoplakia (location (according to the ICD- 10 recommendations (2,24)) were recorded, as well as the clinical form following the WHO’s classification (2,24). In order to determine the size of the lesion fol- lowing Van der Waal (25,26), we recorded the size of the lesion based on the length of the major axis, thus differentiating three groups (0-2 cms, 2-4cms and >4 cms), and finally, single or multiple location (affecting more than one subsite). All these data were collated from the clinical records, in some cases the form and size were determined using clinical photograps from the lesions.
The information on toxic habits, such as smoking (27), we divided them into two groups, smokers and non- smokers, and included in the former current smokers and those who had been smokers in the past 10 years; and in the latter, those who have never smoked or have quit over 10 years prior. As for alcohol, we decided to classify pa- tients as a drinkers and non-drinkers, since in most medi- cal records the amounts are not registered.
Follow-up was performed every 6 or 3 months, depend- ing on the characteristics of the lesion, to assess progress.
-Histopathologic examination
All patients in the study underwent biopsies at the time of initial diagnosis and, in some cases, during the fol- low up, if changes that were likely to become malignant were observed.
The biopsied tissue was fixed in 10% formaldehyde, subsequently embedded in paraffin and processed for routine histological study using the hematoxylin-eosin technique.
Once the tissues were collected, all cases were assessed again by the same oral pathologist and further con- firmed by an independent observer.
Gradation of dysplasia was evaluated according to the criteria of the WHO (28) and classified as mild, moderate and severe. For the survival study, we transformed this variable into a binary: absence / presence of dysplasia.
-Statistical study
All data collected was entered into a database using Mi- crosoft Office Excel 2007 for Windows. Subsequently, the data was tabulated and analyzed statistically using SPSS software for Windows, version 20.0 (SPSS Inc., Chicago, IL, USA).
We carried out a descriptive analysis of clinical and pathological factors. In order to compare means, we used the t student test or the ANOVA single-factor test.
To assess the association between risk factors and trans- formation, we transformed the variables into binary op- tions and used the Pearson chi-square test or Fisher’s exact test, when the frequency for a given variable was less than 5. We also developed a logistic regression analysis to assess the effect of risk.
For the survival analysis, we used the Kaplan-Meier and log-rank tests to assess if the generated survival curves were significantly different. The study time was consid- ered the time from the completion of the first biopsy to the development of cancer (non-censured observation) or until the end of the patient follow-up (censored ob- servation).
All p-values (P) are bilateral, and p-values of 0.05 or less are considered as significant.
Results
-Patient characteristics
The group of 85 patients consisted of 45 men and 40 women, with an average age of 58.68 years (SD = 12.88, and range from 22 to 85).
The most frequently affected site was the tongue (37.6%) followed by gum and buccal mucosa, both in 22.4% of patients. 57.6% of leukoplakia were non homogeneous and, within these, nodular leukoplakia (29.4%) was the most common and 55.3% had more than one affected location. For the initial diagnosis, 62.4% of the biopsies were incisional, while 37.6% were excisional. 44.7%
of patients were smokers, the mean daily consumption was of 24.08 units (SD ± 16.63), with minimum and maximum values of 2 and 100, respectively, the case of the smoker accounting for two units he smoked cigars.
73.7% were heavy smokers (smoking more than 20 ciga- rettes). Smoking was more frequent in the group of men (73.7%). As for alcohol consumption, this information was not included in the medical history of 7 patients;
of the drinkers (35.9%), men accounted for 67.9% con- trasting with 32.1% women (Table 1).
Risk factors Patients
Sex
Men 45 (52.9)
Women 40 (47.1)
Age (years)
<60 43 (50.6)
>60 42 (49.4)
Location
Lip (C00) 3 (3.5)
Tongue (C02) 32 (37.6)
Gum (C03) 19 (22.4)
Floor of the mouth (C04) 7 (8.2)
Palate (C05) 5 (5.9)
Buccal mucosa (C06) 19 (22.4)
Clinical subtype
Homogeneous 36 (42.4)
Non Homogeneous 49 (57.6)
Nodular 25 (29.4)
Spreckled 7 (8.2)
Verrucous 17 (20)
Size of lesion
<2cm 40 (47.1)
2cm-4cms 27 (31.8)
≥4cms 18 (21.2)
Number of lesions
Simple 38 (44.7)
Multiple 47 (55.3)
Smoking habits
Non-smoker 47 (55.3)
Smoker 38 (44.7)
Alcohol consumption
Unknown 7 (8.2)
Non-drinker 50 (64.1)
Drinker 28 (35.9)
Initial histopathologic diagnosis
None 59 (69.4)
Dysplasia 26 (30.6)
Mild 19 (22.4)
Moderate 4 (4.7)
Severe 3 (3.5)
Total 85
Table 1: Characteristics of the studied population.
-Clinical characteristics and relationship with malig- nant transformation
Table 2 presents the results from comparing the clini- cal characteristics between patients who do not suffer transformation and those who did. The men/women af- fectation ratio was 1.1 / 1 for the group in general, when assessing the number of cases that have become malig-
Risk factors No. Patients Histopathologic diagnosis
No CA CA P
Sex 0.702
Men 45 (52.9) 42 (93.3) 3 (6.7)
Women 40 (47.1) 36 (90) 4 (10)
Age (years) 1.000
<60 43 (50.6) 39 (90.7) 4 (9.3)
>60 42 (49.4) 39 (92.9) 3 (7.1)
Location 0.044*
Other locations 46 (54.1) 45 (97.8) 1 (2.2)
Tongue and floor of the mouth 39 (45.9) 33 (84.6) 6 (15.4)
Clinical subtype 0.230
Homogeneous 36 (42.4) 35 (97.2) 1 (2.8)
Non Homogeneous 49 (57.6) 43 (87.8) 6 (12.2)
Size of lesion 1.000
<2cm 40 (47.1) 37 (92.5) 3 (7.5)
≥2cm 45 (52.9) 41 (91.1) 4 (8.9)
No of lesions 1.000
Simple 38 (44.7) 35 (92.1) 3 (7.9)
Multiple 47 (55.3) 43 (91.5) 4 (8.5)
Smoking habits 0.124
Non-smoker 47 (55.3) 41 (87.2) 6 (12.8)
Smoker 38 (44.7) 37 (97.4) 1 (2.6)
Alcohol consumption 1.000
Unknown 7 (8.2) 7 (100) --
No drinker 50 (64.1) 45 (90) 5 (10)
Drinker 28 (35.9) 26 (92.9) 2 (7.1)
Initial histopathologic diagnosis 0.026*
None 59 (91.8) 57 (96.6) 2 (3.4)
Dysplasia 26 (30.6) 21 (80.8) 5 (19.2)
Total 85 78 (91.8) 7 (8.2)
Table 2: Distribution (%) of risk factors and histopathologic diagnosis of the 85 patients and p-values of risk comparison.
nant, the ratio is reversed to 1: 1.3, with women suffer- ing from higher levels of malignant transformation.
The mean age at end of follow-up was 64.14 (95% CI (53.76 to 74.53)) for the group that develops carcinoma
the event at the end of follow-up was 62.69 (95% CI (59.68 to 65.69)). When applying the ANOVA mean comparison test, we note that there are no differences between the two groups.
Table 2 shows that only two of the risk factors: loca- tion and initial histological diagnosis have a statistically significant relationship with malignant transformation.
The tongue and floor of mouth are the preferred loca- tions of malignancy as well as patients with dysplasia at diagnosis. In patients without dysplasia at the beginning of the treatment, we must emphasize that one developed
old male, who smoked over 20 cigarettes per day, which contrasts with the other case, a non-smoking 58.8 year old woman who developed a carcinoma 11 years later.
Of the 7 patients who suffered malignant transforma- tion, carcinoma develops in areas of previous lesions except in a case in which leukoplakia appears in the lat- eral surface of the tongue and the carcinoma develops in the ipsi-lateral alveolar ridge and there was no previ- ous lesion. Two other cases where the initial biopsy was taken at one location and a carcinoma is developed in a different location but is affected by leukoplakia.
-Histopathologic studies of samples
Of the leukoplakia cases showing dysplasia at the initial visit: 19 were mild (21.1%), 4 moderate (4.4%) and 3 severe (3.3%).
-Survival analysis
In our study, 7 (8.2%) of the 85 patients had malignant transformation. The mean follow-up of the 85 patients was 4.13 years (95% CI: (3.36 to 4.89)) versus 5.58 years (95% CI: (1.15 to 10.02)) of those who developed carcinoma.
As we can observe in Figure 1, the Kaplan Meier sur- vival curve for all lesions of the general group without distinction by risk factors. We can see how most of the transformations take place from 5 years of follow-up onwards.
Years OCFs (SE)
1 97.6 (0.016)
5 96.3 (0.021)
7 91.0 (0.056)
8 84.5 (0.081)
11 73.9 (0.122)
Table 3: Proportion of oral cancer free survival (OCFS), in which SE is standard error, throughout the check-ups at 1, 5, 7, 8, and 11 years.
Fig. 1: Kaplan Meier curve analysis of malignant transformation.
In table 3 we see the proportion of malignant transfor- mation free survival (OCFS) during the follow-up at 1, 5, 7, 8 and 11 years. Thus, we see that at 5 years, 96.3%
of the sample was free of transformation. The rate of malignancies at 5 years was 3.7%, as the follow-up pe- riod increases, so does the number of transformations.
We can also see how OCFS takes different values when calculated according to the degree of dysplasia and lo- cation (Table 4). In patients without dysplasia we have estimated an OCFS at five years of 98.3% (0.017) com- pared to 92.1 (0.053) of the group having dysplasia. For
other factors, considering them as independent vari- ables, we conducted a study of binary logistic regres- sion to measure risk, considering malignant transfor- mation as a dependent variable (Table 5).
In Figures 2 and 3, survival curves regarding these risk factors: localization and dysplasia. By comparing the curves with the log rank test, the significance in terms of location (P = 0.058) disappears, in which only the presence of dysplasia remains statistically significant (P
= 0.026).
Therefore, in our samples, we found that the presence of dysplasia is the only risk factor that is statistically related to the development of a carcinoma.
Discussion
Precancerous lesions, leukoplakia in particular, is a dif- ficult field of study due to changes in the nomenclature and definition since they were first described until now.
Also, there are no established criteria for epidemiologi- cal study, so we find recommendations (25,29-31).
Many authors studied oral dysplasia regardless of the clinical lesion from which the samples were taken from, treating all potentially malignant disorders equally.
Few articles carried out the study of oral leukoplakia lesions exclusively and consider only dysplasia from it (4). If we know that the lesion having higher chances of malignization is leukoplakia, we should not treat all dysplasias equally, because in this way we could draw erroneous conclusions regarding the behavior of a par- ticular clinical lesion. Even within leukoplakia we can see different behaviors depending on the consumption habits related to their etiology, as is the case of con- sumption of betel nut, very rare in our society, which is a carcinogenic factor in itself, or in the case of smoking, it would be necessary to establish a criteria first with respect to a classification by smoking habits.
For this reason, we have solely analyzed the lesions that meet the clinical criteria of leukoplakia with anatomic- pathological confirmation.
The rate of malignant transformation, when evaluat- ing all the leukoplakia, regardless of the degree of dys- plasia appearing varies widely from 0.13% to 17.9%
Characteristics Malignization/Total OCFs percentage at 5 years (SE)
OCFs percentage at 11 years (SE)
All patients (85) 7/85 96.3 (0.021) 73.9 (0.122)
Location of lesion
Other locations 1/46 - 75.0 (0.217)
Tongue/floor of the mouth 6/39 92.2 (0.043) 46.9 (0.213)
Initial dysplasia diagnosis
None 2/59 98.3 (0.017) 81.9 (0.150)
Any 5/26 92.1 (0.053) 31.6 (0.240)
Table 4: Oral Cancer Free Survival (OCFs) by degree of dysplasia and location.
Independent variables
(Reference category)
Bivariate models
OR IC 95% p value
Sex (men) 1.55 0.32-7.40 0.579
Age (≥60) 1.33 0.28-6.35 0.728
Tobacco (smoker) 5.41 0.62-47.00 0.126
Alcohol (non-drinker) 1.44 0.26-7.98 0.673
Clinical form (homogeneous) 4.88 0.56-42.49 0.151
Size (<2) 1.2 0.252-5.73 0.816
Number of lesions (one) 1.08 0.22-5.17 0.91
Table 5: Analysis of logistic regression of the risk of developing carcinoma for independent variables.
Fig. 2: Kaplan-Meier curve for location and period free from malig-
nant transformation. Fig. 3: Kaplan-Meier curve for dysplasia and period free from ma-
lignant transformation.
(5,13,18,23,32,33). In our study, 7 of the 85 patients suf- fered malignant transformation representing a transfor- mation ratio of 8.2%. Other authors found similar indi- ces such as Amagasa (10) with a rate of 7.9%.
Regarding the mean follow-up in our group, it was 4.14, while it amounted to 5.58 years in those patients who
suffered malignant transformation. With these results we can conclude that the longer the follow-up time the higher the risk of transformation into carcinoma, as has been shown by other studies (11,13). Authors such as Silverman found a conversion ratio of 6% in its first research and by increasing the follow-up period
it increased to 17.5% (13). Lummerman(34) observed a transformation of dysplastic lesions in 33.6 months and Ho MW (16) observed a mean follow-up time of 48 months, from the first visit to the transformation.
Most studies described cases of appearance of carcino- mas that were distant from the initially described leuko- plakia (3,11,34). Some authors also describe remote ma- lignizations far from the areas affected by leukoplakia in oral mucosa of normal appearance (6,34), all facts supporting the theory of field malignant transformation.
Like other authors (6,34), we found a case of a patient who developed cancer in a remote location of normal- appearing mucosa that was not affected by leukoplakia.
Lee (3) observed that in 41% of patients the cancer was developed in areas far from the initial lesion, this can be explained by the theory of field cancerization (35), according to which any area of mucosa exposed to car- cinogens can develop premalignant changes. Thomson (36) found dysplastic areas in remote areas of the initial lesion and with the appearance of normal oral mucosa in 15 patients. In contrast to our results, Brouns (17) de- scribes that all carcinomas arose in the same location as the initial leukoplakia.
The malignant transformation free period or Oral Cancer Free survival (OCFS) at 5 years was 96.3 (0.021) and 73.9 (0.122) at 11 years. Very few studies calculating the rate of transformation in OCFS, which would be ideal to compare populations, thus we should consider the follow- up time of patients so that the rate of malignant transfor- mation is time-person dependent. We only agreed with Liu (18) in the malignant transformation free period, which differentiates when initial lesions are low risk or high risk, and found a low risk OCFS of 90.6% (95% CI 0.86-0.96) and high risk 61.7% (95% CI 0.44-0.80). As in our study, when we consider the dysplasia-free group we found a greater OCFS than in patients with dysplasia.
The distribution by sex shows a male / female ratio of 1.1:1 similar to other studies (20,34,37). However, this index is inverted when we analyze the cases of malig- nization, 1: 1.3 (men/women), despite this we did not find statistically significant differences in malignization like other authors (17,38), but we did find a higher pro- portion of women who developed carcinoma (6,17,23).
No relationship between the location of the leukoplakia and a greater transformation was found, although the statistically significant association between localization in the tongue and malignization is described in the liter- ature (23). We must keep in mind that most OSCC cases arise from the floor of the mouth, the soft palate and the ventral / lateral tongue surface (39). Epithelia lin- ing the high cancerization risk areas are associated with dysplasia more frequently (40). The trend of dysplasia has been associated to high risk areas to include genetic alterations (loss of heterozygosity LOH at 3p and/or 9p) with a high risk of progression (41) .
Conclusions
The clinicopathological characteristics of the studied leukoplakia in our area were consistent with those found by other authors from countries of Western Europe. We found that non homogeneous lesions pose a risk of de- veloping a carcinoma almost 5 times higher compared to homogeneous lesions Although initially it seemed that the two factors related to the malignant transforma- tion of leukoplakia were the subsite and the presence of dysplasia, ultimately the only factor clearly associ- ated with malignant transformation is the presence of dysplasia of any kind either mild, moderate or severe.
The survival analysis results underline the importance of comprehensive monitoring of these patients and the need to carefully observe any changes that occur in any area of the oral cavity of the patients diagnosed with leukoplakia.
References
1. Petti S.Pooled estimate of world leukoplakia prevalence: a system- atic review. Oral Oncol. 2003;39:770-780.
2. Warnakulasuriya KA, Ralhan R. Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco--a review. J Oral Pathol Med. 2007;36:63-77.
3. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000;6:1702-1710.
4. Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2015;45:155-66
5. Silverman S, Bhargava K, Smith LW, Malaowalla AM. Malignant transformation and natural history of oral leukoplakia in 57,518 in- dustrial workers of Gujarat, India. Cancer. 1976;38:1790-1795.
6. Napier SS, Cowan CG, Gregg TA, Stevenson M, Lamey PJ, Toner PG. Potentially malignant oral lesions in Northern Ireland: size (ex- tent) matters. Oral Dis. 2003;9:129-137.
7. Silverman S Jr, Gorsky M. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:154-157.
8. Scully C. Challenges in predicting which oral mucosal potentially malignant disease will progress to neoplasia. Oral Dis. 2014;20:1-5.
9. Bouquot JE, Speight PM, Farthing PM. Epithelial dysplasia of the oral mucosa—Diagnostic problems and prognostic features. Current Diagnostic Pathology. 2006;12:11-21.
10. Amagasa T, Yamashiro M, Ishikawa H. Oral Leukoplakia Re- lated to Malignant Transformation. Oral Science International.
2006;3:45-55.
11. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Ma- lignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998;34:270-275.
12. Lind PO. Malignant transformation in oral leukoplakia. Scand J Dent Res. 1987;95:449-455.
13. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and ma- lignant transformation. A follow-up study of 257 patients. Cancer.
1984;53:563-568.
14. van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol. 1997;33:291- 301.15. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42:461-474.
16. Ho MW, Risk JM, Woolgar JA, Field EA, Field JK, Steele JC, et al. The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol. 2012;48:969-976.
17. Brouns E, Baart J, Karagozoglu K, Aartman I, Bloemena E, van der Waal I. Malignant transformation of oral leukoplakia in a well- defined cohort of 144 patients. Oral Dis. 2014;20:e19-24 .
18. Liu W, Shi LJ, Wu L, Feng JQ, Yang X, Li J, et al. Oral cancer development in patients with leukoplakia--clinicopathological fac- tors affecting outcome. PLoS One. 2012;7:e34773.
19. Lee JJ, Hung HC, Cheng SJ, Chen YJ, Chiang CP, Liu BY, et al.
Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2006;101:472-480.
20. Liu W, Bao ZX, Shi LJ, Tang GY, Zhou ZT. Malignant transfor- mation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases. Histopa- thology. 2011;59:733-740.
21. Xia RH, Song XM, Wang XJ, Li J, Mao L. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia. PLoS One. 2013;8:e66794.
22. Schaaij-Visser TB, Bremmer JF, Braakhuis BJ, Heck AJ, Slijper M, van der Waal I, et al. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progres- sion of oral leukoplakia. Oral Oncol. 2010;46:123-127.
23. Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT, Tang GY. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 2010;10:685.
24. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mu- cosa. J Oral Pathol Med. 2007;36:575-580.
25. OMS. International Statistical Classification of Diseases and Re- lated Health Problems 10th Revision (ICD-10) http://apps.who.int/
classifications/icd10/browse/2010/en#/C00-C14. Accessed 12 March 2017.
26. van der Waal I, Axell T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol. 2002;38:521-526.
27. Jaber MA. Oral epithelial dysplasia in non-users of tobacco and alcohol: an analysis of clinicopathologic characteristics and treat- ment outcome. J Oral Sci. 2010;52:13-21.
28. Gale N, Pilch BZ, Sidransky D, El Naggar A, Westra W, Califano J, et al. Epithelial precursor lesions. In: Barnes L, Eveson JW, Reich- art P, Sidransky D (ed). World health organization classification of tumours. Pathology and genetics. Head and neck tumours. 1st edn.
IARC Press, Lyon, 2005, pp 177-179.
29. Brouns ER, Baart JA, Bloemena E, Karagozoglu H, van der Waal I. The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients.
Med Oral Patol Oral Cir Bucal 2013;18:19-26.
30. van der Waal I, Schepman KP, van der Meij EH. A modified classification and staging system for oral leukoplakia. Oral Oncol.
2000;36:264-266.
31. Schepman KP, van der Waal I. A proposal for a classification and staging system for oral leukoplakia: a preliminary study. Eur J Cancer B Oral Oncol. 1995;31B:396-398.
32. Chandu A, Smith AC. The use of CO2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence. Int J Oral Maxillofac Surg. 2005;34:396-400.
33. Banoczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg. 1997;5:69-75.
34. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:321-329.
35. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multi- centric origin. Cancer. 1953;6:963-968.
36. Thomson PJ. Field change and oral cancer: new evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg. 2002;31:262- 266.
37. Chandran R, Meer S, Feller L. Oral leukoplakia in a South Afri- can sample: a clinicopathological study. Oral Dis. 2013;19:592-597.
38. Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxil- lofac Surg. 2001;30:49-53.
39. Mashberg A, Meyers H. Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas: a continuing prospec- tive study of oral cancer. II. Cancer. 1076;37:2149-2157.
40. Castagnola P, Malacarne D, Scaruffi P, Maffei M, Donadini A, Di Nallo E, et al. Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue. BMC Cancer. 2011;11:445.
41. Zhang L, Cheung KJ,Jr, Lam WL, Cheng X, Poh C, Priddy R, et al. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer.
2001;91:2148-2155.
Conflict of interest
The authors have declared that no conflict of interest exist.
